Ionis wins FDA approval of Alexander disease drug zilganersen

Ionis Pharmaceuticals got FDA approval of its rare neurodegenerative disease treatment zilganersen, paving the way for the company’s first wholly owned neurology product. Ionis' drug is an RNA-based therapy for children ...